These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11494785)

  • 1. Potential risks and prevention, Part 4: Reports of significant adverse drug events.
    Kelly WN
    Am J Health Syst Pharm; 2001 Aug; 58(15):1406-12. PubMed ID: 11494785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential risks and prevention, Part 3: Drug-induced threats to life.
    Marcellino K; Kelly WN
    Am J Health Syst Pharm; 2001 Aug; 58(15):1399-405. PubMed ID: 11494784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential risks and prevention, Part 2: Drug-induced permanent disabilities.
    Kelly WN
    Am J Health Syst Pharm; 2001 Jul; 58(14):1325-9. PubMed ID: 11471480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential risks and prevention, Part 1: Fatal adverse drug events.
    Kelly WN
    Am J Health Syst Pharm; 2001 Jul; 58(14):1317-24. PubMed ID: 11471479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis.
    Kunac DL; Tatley MV
    Drug Saf; 2011 Jan; 34(1):59-71. PubMed ID: 21142271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports.
    Winterstein AG; Hatton RC; Gonzalez-Rothi R; Johns TE; Segal R
    Am J Health Syst Pharm; 2002 Sep; 59(18):1742-9. PubMed ID: 12298112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication errors: an analysis comparing PHICO's closed claims data and PHICO's Event Reporting Trending System (PERTS).
    Benjamin DM; Pendrak RF
    J Clin Pharmacol; 2003 Jul; 43(7):754-9. PubMed ID: 12856390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.
    Bates DW; Cullen DJ; Laird N; Petersen LA; Small SD; Servi D; Laffel G; Sweitzer BJ; Shea BF; Hallisey R
    JAMA; 1995 Jul; 274(1):29-34. PubMed ID: 7791255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and preventability of adverse drug events among older persons in the ambulatory setting.
    Gurwitz JH; Field TS; Harrold LR; Rothschild J; Debellis K; Seger AC; Cadoret C; Fish LS; Garber L; Kelleher M; Bates DW
    JAMA; 2003 Mar; 289(9):1107-16. PubMed ID: 12622580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug events and medication errors: detection and classification methods.
    Morimoto T; Gandhi TK; Seger AC; Hsieh TC; Bates DW
    Qual Saf Health Care; 2004 Aug; 13(4):306-14. PubMed ID: 15289635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computerized surveillance of adverse drug events in hospital patients.
    Classen DC; Pestotnik SL; Evans RS; Burke JP
    JAMA; 1991 Nov; 266(20):2847-51. PubMed ID: 1942452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nature of preventable adverse drug events in hospitals: a literature review.
    Kanjanarat P; Winterstein AG; Johns TE; Hatton RC; Gonzalez-Rothi R; Segal R
    Am J Health Syst Pharm; 2003 Sep; 60(17):1750-9. PubMed ID: 14503111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detecting adverse drug events during the hospital stay].
    Berga Culleré C; Gorgas Torner MQ; Altimiras Ruiz J; Tuset Creus M; Besalduch Martín M; Capdevila Sunyer M; Torres Gubert M; Casajoana Cortinas MT; Baró Sabaté E; Fernández Solà JR; Moron i Besolí A; Odena Estradé E; Serrais Benavente J; Vitales Farrero MT; Codina Jané C
    Farm Hosp; 2009; 33(6):312-23. PubMed ID: 20038390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of adverse drug events and medication errors in intensive care units: a prospective multicenter study.
    Benkirane RR; Abouqal R; Haimeur CC; S Ech Cherif El Kettani SS; Azzouzi AA; Mdaghri Alaoui AA; Thimou AA; Nejmi MM; Maazouzi WW; Madani NN; R-Edwards I; Soulaymani RR
    J Patient Saf; 2009 Mar; 5(1):16-22. PubMed ID: 19920434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of preventable adverse drug events: a review of the literature.
    von Laue NC; Schwappach DL; Koeck CM
    Wien Klin Wochenschr; 2003 Jul; 115(12):407-15. PubMed ID: 12918183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database.
    Sonawane KB; Cheng N; Hansen RA
    J Manag Care Spec Pharm; 2018 Jul; 24(7):682-690. PubMed ID: 29952714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventability of adverse drug events involving multiple drugs using publicly available clinical decision support tools.
    Wright A; Feblowitz J; Phansalkar S; Liu J; Wilcox A; Keohane CA; Seger DL; Bloomrosen M; Kuperman GJ; Bates DW
    Am J Health Syst Pharm; 2012 Feb; 69(3):221-7. PubMed ID: 22261944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying drug safety issues: from research to practice.
    Gandhi TK; Seger DL; Bates DW
    Int J Qual Health Care; 2000 Feb; 12(1):69-76. PubMed ID: 10733086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventable adverse drug events and their causes and contributing factors: the analysis of register data.
    Jylhä V; Saranto K; Bates DW
    Int J Qual Health Care; 2011 Apr; 23(2):187-97. PubMed ID: 21242162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of adverse drug events and medication errors among psychiatric inpatients in Japan: the JADE study.
    Ayani N; Sakuma M; Morimoto T; Kikuchi T; Watanabe K; Narumoto J; Fukui K
    BMC Psychiatry; 2016 Aug; 16(1):303. PubMed ID: 27577925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.